CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Topoisomerase Inhibitors [MoA] Bronchitis [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Escherichia coli Infections [Disease/Finding] Klebsiella Infections [Disease/Finding] Proteus Infections [Disease/Finding] Pseudomonas Infections [Disease/Finding] Staphylococcal Infections [Disease/Finding] Streptococcal Infections [Disease/Finding] Urinary Tract Infections [Disease/Finding] lomefloxacin [Chemical/Ingredient] Decreased DNA Integrity [PE] Increased Protein Breakdown [PE] L [Preparations] LOMEFLOXACIN http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20013s015lbl.pdf <VANDF_Record>50.416^3183^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3183</VA_IEN> lomefloxacin <VANDF_Record>50.6^2698^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>2698</VA_IEN> Ingredient LOMEFLOXACIN L6BR2WJD8V N0000148250 C16602 28872 4020537 C0065162 Active bronchitis headache AE dizziness AE abdominal pain AE nausea AE photosensitivity reaction AE